![]()
|
|
||||||||
J. Biol. Chem., Vol. 259, Issue 21, 12949-12951, Nov, 1984
KG Mann, CM Lawler, GA Vehar and WR Church
Preparations of bovine and human coagulation Factor V were analyzed for copper using both atomic absorption and atomic emission spectroscopy. All preparations of the bovine and human protein were found to contain copper ion at a ratio of 1 copper ion bound per mol (Mr = 330,000) of Factor V. As a result of copper binding and sequence homology between ceruloplasmin and Factor V, bovine Factor V and thrombin-activated Factor V (Va) were assessed with respect to their visible and near ultraviolet absorption spectra and to their ability to oxidize N,N- dimethyl-p-phenylenediamine (a substrate for ceruloplasmin). Factor V and Factor Va exhibited absorption spectra with no maxima at either 310 or 610 nm, indicating that the copper is not bound in a site analogous to Type I or Type III copper sites in ceruloplasmin. Further, Factor V and Factor Va are not capable of serving as catalysts for the oxidation of N,N-dimethyl-p-phenylenediamine under solution conditions that are optimum for ceruloplasmin oxidase activity. These data suggest that the copper ion bound to Factor V may be functionally and structurally distinct from the Type I and Type III copper ion bound to ceruloplasmin.
This article has been cited by other articles:
![]() |
B. W. Shen, P. C. Spiegel, C.-H. Chang, J.-W. Huh, J.-S. Lee, J. Kim, Y.-H. Kim, and B. L. Stoddard The tertiary structure and domain organization of coagulation factor VIII Blood, February 1, 2008; 111(3): 1240 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Adams, M. F. Hockin, K. G. Mann, and S. J. Everse The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function PNAS, June 15, 2004; 101(24): 8918 - 8923. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. S. Rao, S. Swarup, and R. M. Kini The nonenzymatic subunit of pseutarin C, a prothrombin activator from eastern brown snake (Pseudonaja textilis) venom, shows structural similarity to mammalian coagulation factor V Blood, August 15, 2003; 102(4): 1347 - 1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Mann and M. Kalafatis Factor V: a combination of Dr Jekyll and Mr Hyde Blood, January 1, 2003; 101(1): 20 - 30. [Full Text] [PDF] |
||||
![]() |
S. W. Pipe, E. L. Saenko, A. N. Eickhorst, G. Kemball-Cook, and R. J. Kaufman Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa Blood, February 1, 2001; 97(3): 685 - 691. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tagliavacca, N. Moon, W. R. Dunham, and R. J. Kaufman Identification and Functional Requirement of Cu(I) and Its Ligands within Coagulation Factor VIII J. Biol. Chem., October 24, 1997; 272(43): 27428 - 27434. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Undas, E. B. Williams, S. Butenas, T. Orfeo, and K. G. Mann Homocysteine Inhibits Inactivation of Factor Va by Activated Protein C J. Biol. Chem., February 2, 2001; 276(6): 4389 - 4397. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Zeibdawi and E. L. G. Pryzdial Mechanism of Factor Va Inactivation by Plasmin. LOSS OF A2 AND A3 DOMAINS FROM A Ca2+-DEPENDENT COMPLEX OF FRAGMENTS BOUND TO PHOSPHOLIPID J. Biol. Chem., June 1, 2001; 276(23): 19929 - 19936. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |